IBDEI0C4 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5751,2)
 ;;=^123941
 ;;^UTILITY(U,$J,358.3,5752,0)
 ;;=275.40^^49^516^2
 ;;^UTILITY(U,$J,358.3,5752,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5752,1,4,0)
 ;;=4^METABOLISM D/O,CALCIUM
 ;;^UTILITY(U,$J,358.3,5752,1,5,0)
 ;;=5^275.40
 ;;^UTILITY(U,$J,358.3,5752,2)
 ;;=^18161
 ;;^UTILITY(U,$J,358.3,5753,0)
 ;;=275.2^^49^516^3
 ;;^UTILITY(U,$J,358.3,5753,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5753,1,4,0)
 ;;=4^METABOLISM D/O,MAGNESIUM
 ;;^UTILITY(U,$J,358.3,5753,1,5,0)
 ;;=5^275.2
 ;;^UTILITY(U,$J,358.3,5753,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,5754,0)
 ;;=275.3^^49^516^5
 ;;^UTILITY(U,$J,358.3,5754,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5754,1,4,0)
 ;;=4^METABOLISM D/O,PHOSPHORUS
 ;;^UTILITY(U,$J,358.3,5754,1,5,0)
 ;;=5^275.3
 ;;^UTILITY(U,$J,358.3,5754,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,5755,0)
 ;;=275.9^^49^516^4
 ;;^UTILITY(U,$J,358.3,5755,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5755,1,4,0)
 ;;=4^METABOLISM D/O,MINERAL
 ;;^UTILITY(U,$J,358.3,5755,1,5,0)
 ;;=5^275.9
 ;;^UTILITY(U,$J,358.3,5755,2)
 ;;=^267943
 ;;^UTILITY(U,$J,358.3,5756,0)
 ;;=588.0^^49^516^13
 ;;^UTILITY(U,$J,358.3,5756,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5756,1,4,0)
 ;;=4^RENAL OSTEODYSTROPHY
 ;;^UTILITY(U,$J,358.3,5756,1,5,0)
 ;;=5^588.0
 ;;^UTILITY(U,$J,358.3,5756,2)
 ;;=^104747
 ;;^UTILITY(U,$J,358.3,5757,0)
 ;;=268.9^^49^516^14
 ;;^UTILITY(U,$J,358.3,5757,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5757,1,4,0)
 ;;=4^VITAMIN D DEFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,5757,1,5,0)
 ;;=5^268.9
 ;;^UTILITY(U,$J,358.3,5757,2)
 ;;=^126968
 ;;^UTILITY(U,$J,358.3,5758,0)
 ;;=251.2^^49^517^16
 ;;^UTILITY(U,$J,358.3,5758,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5758,1,4,0)
 ;;=4^HYPOGLYCEMIA NOS
 ;;^UTILITY(U,$J,358.3,5758,1,5,0)
 ;;=5^251.2
 ;;^UTILITY(U,$J,358.3,5758,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,5759,0)
 ;;=250.01^^49^517^7
 ;;^UTILITY(U,$J,358.3,5759,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5759,1,4,0)
 ;;=4^DMI w/o COMPLICATIONS
 ;;^UTILITY(U,$J,358.3,5759,1,5,0)
 ;;=5^250.01
 ;;^UTILITY(U,$J,358.3,5759,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,5760,0)
 ;;=250.11^^49^517^3
 ;;^UTILITY(U,$J,358.3,5760,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5760,1,4,0)
 ;;=4^DMI w/ KETOACIDOSIS
 ;;^UTILITY(U,$J,358.3,5760,1,5,0)
 ;;=5^250.11
 ;;^UTILITY(U,$J,358.3,5760,2)
 ;;=^331784
 ;;^UTILITY(U,$J,358.3,5761,0)
 ;;=250.21^^49^517^2
 ;;^UTILITY(U,$J,358.3,5761,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5761,1,4,0)
 ;;=4^DMI w/ HYPEROSMOLARITY
 ;;^UTILITY(U,$J,358.3,5761,1,5,0)
 ;;=5^250.21
 ;;^UTILITY(U,$J,358.3,5761,2)
 ;;=^331788
 ;;^UTILITY(U,$J,358.3,5762,0)
 ;;=250.41^^49^517^5
 ;;^UTILITY(U,$J,358.3,5762,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5762,1,4,0)
 ;;=4^DMI w/ RENAL COMPL
 ;;^UTILITY(U,$J,358.3,5762,1,5,0)
 ;;=5^250.41
 ;;^UTILITY(U,$J,358.3,5762,2)
 ;;=^331796
 ;;^UTILITY(U,$J,358.3,5763,0)
 ;;=250.51^^49^517^1
 ;;^UTILITY(U,$J,358.3,5763,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5763,1,4,0)
 ;;=4^DMI w/ EYE COMPL
 ;;^UTILITY(U,$J,358.3,5763,1,5,0)
 ;;=5^250.51
 ;;^UTILITY(U,$J,358.3,5763,2)
 ;;=^331800
 ;;^UTILITY(U,$J,358.3,5764,0)
 ;;=250.61^^49^517^4
 ;;^UTILITY(U,$J,358.3,5764,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5764,1,4,0)
 ;;=4^DMI w/ NEUROLOGICAL COMPL
 ;;^UTILITY(U,$J,358.3,5764,1,5,0)
 ;;=5^250.61
 ;;^UTILITY(U,$J,358.3,5764,2)
 ;;=^331804
 ;;^UTILITY(U,$J,358.3,5765,0)
 ;;=250.71^^49^517^6
 ;;^UTILITY(U,$J,358.3,5765,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,5765,1,4,0)
 ;;=4^DMI w/ VASCULAR COMPL
 ;;^UTILITY(U,$J,358.3,5765,1,5,0)
 ;;=5^250.71
